AI assistant
Sending…
AtriCure, Inc. — Director's Dealing 2022
Mar 7, 2022
31802_dirs_2022-03-07_572499c1-08cc-4e52-a729-a6e4c14db5e2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2022-03-03
Reporting Person: WHITE ROBERT S. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-03 | Common Stock | M | 15000 | $8.48 | Acquired | 37235 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-03-03 | Non-qualified Stock Option (right to buy) | $8.48 | M | 15000 | Disposed | 2023-03-11 | Non-qualified Stock Option (right to buy) (15000.0) | Direct |
Footnotes
F1: These options were granted on March 11, 2013. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.
More from AtriCure, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 6
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3